Targeted immunotherapy for pediatric solid tumors

Lisa M. Kopp; Emmanuel Katsanis

doi:10.1080/2162402X.2015.1087637

Targeted immunotherapy for pediatric solid tumors

Lisa M. Kopp, Emmanuel Katsanis

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

Original language	English (US)
Journal	OncoImmunology
Volume	5
Issue number	3
DOIs	https://doi.org/10.1080/2162402X.2015.1087637
State	Published - Mar 3 2016

Keywords

Immunotherapy
pediatric oncology
solid tumors

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Oncology

Access to Document

10.1080/2162402X.2015.1087637

Cite this

@article{0eeefa60e6844f0189afc5129dda9d7b,

title = "Targeted immunotherapy for pediatric solid tumors",

abstract = "ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.",

keywords = "Immunotherapy, pediatric oncology, solid tumors",

author = "Kopp, {Lisa M.} and Emmanuel Katsanis",

note = "Publisher Copyright: {\textcopyright} 2016, {\textcopyright} Taylor & Francis Group, LLC.",

year = "2016",

month = mar,

day = "3",

doi = "10.1080/2162402X.2015.1087637",

language = "English (US)",

volume = "5",

journal = "OncoImmunology",

issn = "2162-4011",

publisher = "Landes Bioscience",

number = "3",

}

TY - JOUR

T1 - Targeted immunotherapy for pediatric solid tumors

AU - Kopp, Lisa M.

AU - Katsanis, Emmanuel

PY - 2016/3/3

Y1 - 2016/3/3

N2 - ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

AB - ABSTRACT: Metastatic and refractory pediatric solid tumor malignancies continue to have a poor outcome despite the > 80% cure rates appreciated in many pediatric cancers. Targeted immunotherapy is impacting treatment and survival in these aggressive tumors. We review current promising immunotherapeutic approaches in the pediatric oncology solid tumor setting.

KW - Immunotherapy

KW - pediatric oncology

KW - solid tumors

UR - http://www.scopus.com/inward/record.url?scp=84961576020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961576020&partnerID=8YFLogxK

U2 - 10.1080/2162402X.2015.1087637

DO - 10.1080/2162402X.2015.1087637

M3 - Review article

AN - SCOPUS:84961576020

SN - 2162-4011

VL - 5

JO - OncoImmunology

JF - OncoImmunology

IS - 3

ER -

Targeted immunotherapy for pediatric solid tumors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this